D.E. Shaw & Co
KALA icon

D.E. Shaw & Co’s KALA BIO KALA Stock Holding History

D.E. Shaw & Co’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12
Closed -$41K – 5548
2022
Q1 		$41K Sell
12
-31
-72% -$81.2K ﹤0.01% 5192
2021
Q4 		$130K Buy
+43
New +$199K ﹤0.01% 5002
2021
Q2 		– Sell
-14
Closed -$235K – 4877
2021
Q1 		$235K Buy
14
+1
+8% +$19.5K ﹤0.01% 3794
2020
Q4 		$221K Buy
13
+3
+30% +$56.4K ﹤0.01% 3706
2020
Q3 		$190K Sell
10
-59
-86% -$1.36M ﹤0.01% 3609
2020
Q2 		$1.81M Buy
69
+47
+214% +$1.33M ﹤0.01% 2497
2020
Q1 		$489K Buy
+22
New +$351K ﹤0.01% 3222
2019
Q2 		– Sell
-18
Closed -$369K – 3753
2019
Q1 		$369K Sell
18
-25
-58% -$444K ﹤0.01% 3131
2018
Q4 		$531K Buy
43
+34
+378% +$589K ﹤0.01% 3063
2018
Q3 		$215K Buy
+9
New +$274K ﹤0.01% 3513
2018
Q2 		– Sell
-12
Closed -$463K – 3791
2018
Q1 		$463K Buy
+12
New +$456K ﹤0.01% 2922

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

D.E. Shaw & Co's KALA Position: Q2 2022 in Review

D.E. Shaw & Co sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 12 shares — an estimated $41K sold.

D.E. Shaw & Co first reported a position in KALA in Q1 2018 and held it in 11 quarters. The position peaked at $1.81M in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • D.E. Shaw & Co reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 12 KALA BIO shares in Q2 2022, an estimated $41K.
  • D.E. Shaw & Co first reported a position in KALA BIO in Q1 2018 and held it in 11 quarters.
  • D.E. Shaw & Co's KALA BIO position peaked at $1.81M in Q2 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.